379 results
Page 10 of 19
8-K
v2vt36qw9yl
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am
424B5
v72s isgqrla19
28 Apr 10
Prospectus supplement for primary offering
12:00am
8-K
hre8ttibta9tucvpi6
26 Feb 10
Discovery Labs Announces Completion of
12:00am
424B5
dskczkbb dxytyf0c
19 Feb 10
Prospectus supplement for primary offering
12:00am
424B5
uw5pl ds8eder7a2t
17 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
2dmegbf7ex99
16 Feb 10
Other Events
12:00am
S-8
EX-4.1
sx5u0 5i6etgpal
22 Jan 10
Registration of securities for employees
12:00am
8-K
ntxzz
4 Dec 09
Discovery Labs Receives Nasdaq Notification Related
12:00am
8-K
nhd6 suiucz
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
bc9k 29jfw8u9iqvgw0
30 Sep 09
Discovery Labs and FDA Establish Path for Potential SURFAXIN Approval
12:00am
8-K
idt13ip
11 Sep 09
Other Events
12:00am
8-K
nzr9iwvv2enm zi
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
f9wi4qfi30wnic
19 Aug 09
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
12:00am
8-K
o27ze3e
3 Aug 09
Discovery Labs Provides Second Quarter 2009 Financial Results and Business Strategy Update
12:00am